Amarin's Vascepa May Face Generic Competition In US Next Year After Patents Ruled Invalid

 
• By Brenda Sandburg
  
Fish oil
Court rules patents on Amarin's fish oil pill Vascepa are invalid
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Business